← Leaderboards
Peng Jin
Effigene Pharmaceuticals, Inc.
$248,982
Attributed
$248,982
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $115.4K · FY2008–10$200K$150K$100K$50K$0
'08
'09
'10
Funding mix
By agency
NIH$248,982 · 2
By mechanism
R41$248,982 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsFutureDoseDiabetes MellitusAdverse EffectsFunctional GenomicsApoptosisAge Related Macular DegenerationAdjuvant TherapyDesignBase PairingAnimal ModelAntineoplastic AgentsEnhancersCell MaintenanceCellsArchitectureCholesterolChromosomesAsthmaClinical TrialsBaseCommunicable DiseasesGene Expression